Related Experiment Video

Updated: Jul 11, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Novel cytotoxic drugs: old challenges, new solutions

Gustavo F V Ismael1, Daniela Dornelles Rosa, Max S Mano

  • 1Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Belgium.

Cancer Treatment Reviews
|October 2, 2007
PubMed

Insights

Novel cytotoxic agents offer improved cancer treatment by enhancing efficacy and safety. These new drugs aim to overcome resistance and reduce side effects for better patient outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Development

Background:

  • Cytotoxic agents revolutionized cancer therapy, improving patient survival and quality of life.
  • Challenges remain in developing anticancer drugs with optimal efficacy, safety, and convenience.
  • Existing drugs face limitations such as narrow therapeutic index, damage to healthy tissues, and drug resistance.

Purpose of the Study:

  • To review the development of novel cytotoxic drugs.
  • To highlight agents offering improved efficacy, safety, and tolerability.
  • To discuss advancements addressing limitations of conventional chemotherapy.

Main Methods:

  • Literature review of recent advancements in cytotoxic drug development.
  • Analysis of novel agents focusing on mechanisms of action and therapeutic benefits.
  • Evaluation of safety profiles and convenience factors of new cytotoxic drugs.

Main Results:

  • Novel cytotoxic agents demonstrate advantages over conventional ones.
  • These include shorter administration times and mechanisms to overcome drug resistance.
  • Reduced incidence of adverse events is a key benefit of newer agents.

Conclusions:

  • Promising novel cytotoxic drugs are emerging in cancer treatment.
  • These agents are expected to enhance efficacy while improving safety and tolerability.
  • Future developments aim for more convenient and effective cancer therapies.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...